52-Week High:Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) $49.72. Intra-Cellular Therapies ramping after it announced positive results from the first Phase ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Canaccord Genuity Reiterates Buy on Under Armour (UA) Following Investor Day September 17, 2015 9:15 AM Cowen Raises Price Target on Under Armour (UA) to $120 Following Investor Day September 17, 2015 8:44 AM Sterne Agee CRT Reiterates Buy on Under Armour (UA) Following Investor Day September 17, 2015 8:13 AM Piper Jaffray Remains Bullish on Under Armour (UA) Following Analyst Day September 17, 2015 6:46 AM